共 50 条
Making a case "for" focal therapy of the prostate in intermediate risk prostate cancer: current perspective and ongoing trials
被引:10
作者:
Wang, Alex Z.
[1
]
Lebastchi, Amir H.
[1
,9
]
O'Connor, Luke P.
[1
]
Ahdoot, Michael
[1
]
Mehralivand, Sherif
[2
]
Yerram, Nitin
[1
]
Taneja, Samir S.
[3
]
George, Arvin K.
[4
]
Sanchez-Salas, Rafael
[5
,6
]
Ward, John F.
[7
]
Laguna, Pilar
[8
]
de la Rosette, Jean
[8
]
Pinto, Peter A.
[1
]
机构:
[1] NCI, Urol Oncol Branch, NIH, Bethesda, MD 20892 USA
[2] NCI, Mol Imaging Branch, NIH, Bethesda, MD 20892 USA
[3] NYU, Sch Med, Dept Urol, Div Urol Oncol,NYU Langone Hlth, New York, NY 10003 USA
[4] Michigan Med, Dept Urol, Ann Arbor, MI USA
[5] Inst Mutualiste Montsouris, Dept Urol, Paris, France
[6] Univ Paris 05, Paris, France
[7] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA
[8] Istanbul Medipol Univ, Dept Urol, Istanbul, Turkey
[9] 10 Ctr Dr,Bldg 10,Room 1-5950, Bethesda, MD 20892 USA
关键词:
Focal therapy;
prostate cancer;
MRI;
WHOLE-GLAND CRYOTHERAPY;
RADICAL PROSTATECTOMY;
LASER-ABLATION;
ACTIVE SURVEILLANCE;
UNITED-STATES;
INDEX LESION;
FOLLOW-UP;
OUTCOMES;
MORTALITY;
RADIATION;
D O I:
10.1007/s00345-020-03525-0
中图分类号:
R5 [内科学];
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号:
1002 ;
100201 ;
摘要:
Focal therapy is growing as an alternative management options for men with clinically localized prostate cancer. Parallel to the increasing popularity of active surveillance (AS) as a treatment for low-risk disease, there has been an increased interest towards providing focal therapy for patients with intermediate-risk disease. Focal therapy can act as a logical "middle ground" in patients who seek treatment while minimizing potential side effects of definitive whole-gland treatment. The aim of the current review is to define the rationale of focal therapy in patients with intermediate-risk prostate cancer and highlight the importance of patient selection in focal therapy candidacy.
引用
收藏
页码:729 / 739
页数:11
相关论文
共 50 条